TransMedics Group, Inc. (NASDAQ:TMDX – Get Free Report) Director David Weill purchased 1,336 shares of the firm’s stock in a transaction that occurred on Friday, September 11th. The shares were acquired at an average cost of $81.63 per share, with a total value of $109,057.68. Following the completion of the transaction, the director owned 16,392 […]